Aldactazide and Breastfeeding
Women are generally advised to avoid Aldactazide while breastfeeding. It could cause problems for the nursing infant because both components of the medication are known to pass through breast milk. Spironolactone (a component of Aldactazide) can decrease male hormones, so it may be especially dangerous for breastfeeding boys. If you are taking Aldactazide and breastfeeding (or thinking of starting), let your healthcare provider know.
Aldactazide® (spironolactone-HCTZ) is passed through breast milk. Because of the potentially serious side effects that could occur in the nursing infant, the manufacturer does not recommend breastfeeding while taking the drug. Therefore, if you are breastfeeding or thinking of breastfeeding, make sure to let your healthcare provider know.
Aldactazide is a combination of two diuretics: hydrochlorothiazide (HCTZ) and spironolactone. Both diuretics are passed through breast milk. It is not known what the effects might be on a nursing infant. Because spironolactone can block or decrease male hormones, it may be especially dangerous for breastfeeding boys. If your healthcare provider decides that it is okay for you to take Aldactazide while breastfeeding, be sure to watch for any side effects or changes in your baby.
You should talk with your healthcare provider about Aldactazide and breastfeeding. Each woman's situation is different, and you and your healthcare provider understand your situation best. Based on what you want and expect, as well as your current health situation, the two of you can make a shared decision about Aldactazide and breastfeeding that is right for you.